Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1995
Invasive colitis and hepatitis due to previously uncharacterized spirochetes in patients with advanced human immunodeficiency virus infectionJ R Kostman, M Patel, E Catalano, et al.
Blood|July 27, 1999
The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individualsJ D Marshall, J Chehimi, G Gri, et al.
Chemotherapy|July 1, 1996
The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococciG S Itokazu, C Nathan, R Hariharan, et al.
The Journal of Infectious Diseases|January 1, 1995
A universal approach to bacterial molecular epidemiology by polymerase chain reaction ribotypingJ R Kostman, M B Alden, M Mair, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1993
Invasive Haemophilus influenzae infections in older children and adults in SeattleJ R Kostman, B L Sherry, C L Fligner, et al.
Journal of Viral Hepatitis|April 19, 2017
HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjectsE Papasavvas, L Azzoni, X Yin, et al.
HIV Medicine|December 12, 2001
The effects of an HIV-1 immunogen (Remune) on viral load, CD4 cell counts and HIV-specific immunity in a double-blind, randomized, adjuvant-controlled subset study in HIV infected subjects regardless of concomitant antiviral drugsJ L Turner, J R Kostman, A Aquino, et al.
Journal of Viral Hepatitis|March 7, 2014
Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapyJ S Hafkin, M K Osborn, A R Localio, et al.
Journal of Viral Hepatitis|March 11, 2015
Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfectionD D Byrne, C W Newcomb, D M Carbonari, et al.
The Journal of Infectious Diseases|August 19, 2000
Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruptionE Papasavvas, G M Ortiz, R Gross, et al.
Pageof 2